Xbiotech Inc. (XBIT) SEC Filings — 2025
13 SEC filings for Xbiotech Inc. (XBIT) in 2025.
Filings
- XBiotech Inc. Announces Director Changes and Officer Compensation — 8-K · Dec 9, 2025
- XBiotech Narrows 9-Month Loss to $18.6M, Cash Dips to $147M — 10-Q · Nov 12, 2025
- XBiotech Inc. Amends 8-K Filing on Officer/Director Changes — 8-K/A · Oct 15, 2025
- XBiotech Reports Material Agreement, Officer/Director Changes — 8-K · Oct 3, 2025
- XBiotech Inc. Files 8-K on Shareholder Vote Matters — 8-K · Sep 2, 2025
- XBiotech Narrows Q2 Loss on Reduced R&D, Cash Reserves at $152.9M — 10-Q · Aug 13, 2025
- XBiotech Sets Shareholder Meeting, Proposes 2025 Equity Plan — DEF 14A · Jul 7, 2025
- XBiotech Inc. Reports Board and Executive Compensation Changes — 8-K · Jun 24, 2025
- XBiotech Inc. Files Q1 2025 10-Q — 10-Q · May 14, 2025
- XBiotech Files 10-K/A Amendment — 10-K/A · Apr 29, 2025
- XBiotech Inc. Faces Delisting Notice — 8-K · Apr 7, 2025
- XBiotech Inc. Reports Director and Officer Changes — 8-K · Apr 1, 2025
- XBiotech Inc. Files 2024 10-K — 10-K · Mar 18, 2025